Association of polymorphism in cytochrome P450 2D6 and N-acetyltransferase- 2 with Parkinson's disease

Disease Markers

Volumn 28, Issue 2, 2010, Pages 87-93

  Singh, Madhu ^a   Khanna, Vinay K ^a   Shukla, Rakesh ^b   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cytochrome P450 2D6; N acetyltransferase 2; parkinson disease; poor metabolizers; risk

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 2D6; NAT2 PROTEIN, HUMAN;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME METABOLISM; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; ALLELE; ENZYMOLOGY; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2D6; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; YOUNG ADULT;

EID: 77954048329     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0688     Document Type: Article

References (30)

1. P. Jenner, Oxidative stress in Parkinson's disease, Ann Neurol 53 (2003), S26-S36.
2. S. Ohta, M. Kohno, Y. Makino, O. Tachikawa and O. Hirobe, Tetrahydroisiquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease, Biomed Res 8 (1987), 453-456.
3. B.S. Harhangi, B.A. Oostra, P. Heutink, C.M. van Duijn, A. Hofman and M.M.B. Breteler, N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study, J Neurol Neurosurg Psychiatry 67 (1999), 518-520.
4. M.C.Kurth and J.H.Kurth, Variant cytochrome P450CYP2D6 allelic frequencies in Parkinson's disease, Am J Med Genet 48 (1993), 166-168.
5. A.S. Persad, T. Stedeford, S. Tanaka, L. Chen and M. Banasik, Parkinson's disease and CYP2D6 polymorphism in Asian populations: a meta-analysis, Neuroepidemiology 22 (2003), 357-361.
6. S.J. McCann, S.M. Pond, K.M. James and D.G. Le Couteur, The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis, J Neurol Sci 153 (1997), 50-53.
7. S.L. Ho, M.H.W.Kung, L.S.W. Li, I.J. Lauder and D.B. Ramsden, Cytochrome P4502d6 (debrisoquine 4-hydroxylase) and Parkinson' disease in Chinese and Caucasians, Eur J Neurol 6 (1999), 323-329.
8. D.A. Evans, N-acetyltransferase, Pharmacol Ther 42 (1989), 157-234.
9. O. Bandmann, J. Vaughan, P. Holmans, C.D. Marsden and N.W. Wood, Association of slow acetylator genotype for Nacetyltransferase 2 with familial Parkinson's disease, Lancet 350 (1997), 1136-1139.
10. D.A. Evans, Survey of the human acetylator polymorphism in spontaneous disorders, J Med Genet 21 (1984), 243-253.
11. O. Bandmann, J. Vaughan, P. Holmans, C.D. Marsden and N.W. Wood, Detailed genotyping demonstrates association between the slow acetylator genotype for N-acetyltransferase 2 (NAT-2) and familial Parkinson's disease, Mov Disord 15 (2000), 30-35.
12. M. Bialecka, M. Drozdzik and H. Podraza, Role of gene polymorphism of catechol-O-methyltransferase (COMT), monoamine oxidase B (MAO-B), cytochrome P450 2D6 (CYP2D6) and N-acetyltransferase 2 (NAT-2) in pathogenesis of Parkinson's disease, Neurol Neurochir Pol 36 (2002), 113-121.
13. D.K. Chan, M.K. Lam, R.Wong, W.T. Hung and D.E.Wilcken, Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese, Neurology 60 (2003), 1002-1005.
14. S. Chaudhary, M. Behari, M. Dihana, P.V. Swaminath, S.T. Govindappa, S. Jayaram, S. Singh, U. Muthane, R.C. Juyal and B.K. Thelma, Association of n-acetyltransferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians, Pharmacogenet Genomics 15 (2005), 731-735.
15. M. Singh, A.J. Khan, P.P. Shah, R. Shukla, V.K. Khanna and D. Parmar, Polymorphism in environment responsive genes and association with Parkinson disease, Mol Cell Biochem 312 (2008), 131-138.
16. H. Yokota, S. Tamura, H. Furuya, S. Kimura, M. Watanabe, I. Kanazawa, I. Kondo and F.J. Gonzalez, Evidence for a new variant CYP2D6 allele CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism, Pharmacogenetics 3 (1993), 256-263.
17. Y. Tsuneoka, Y. Matsuo, K. Iwahashi, H. Takeuchi and Y. Ichikawa, A novel cytochrome P-450IID6 mutant genes associated with Parkinson's disease, J Biochem 114 (1993), 263-266.
18. B.C. Schur, J. Bjerke, N. Nuwayhid and S.H. Wong, Genotyping of cytochrome P450 2D6*3 and *4 mutations using conventional PCR, Clin Chim Acta 308 (2001), 25-31.
19. D.A. Bell, J.A. Taylor, M.A. Butler, E.A. Stephens, J. Wiest, L.H. Brubaker, F.F. Kadlubar and G.W. Lucier, Genotype/phenotype discordance for human arylamine Nacetyltransferase (NAT2) reveals a new slow acetylator allele common in African-Americans, Carcinogenesis 14 (1993), 1689-1692.
20. L.D. Bradford, CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants, Pharmacogenomics 3 (2002), 229-243.
21. M. Kagimoto, M. Heim, K. Kagimoto, T. Zeugin and U.A. Meyer, Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes, J Biol Chem 265 (1990), 17209-17214.
22. S.L. Wang, J.D. Huang, M.D. Lai, B.H. Liu and M.L. Lai, Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6, Clin Pharmacol Ther 53 (1993), 410-418.
23. I. Kondo and I. Kanazawa, Debrisoquine hydroxylase and Parkinson's disease, Adv Neurol 60 (1993), 338-342.
24. Y.J. Liou, Y.C. Wang, Y.M. Bai, C.C. Lin, S.C. Yu SC, D.L. Liao, M.W. Lin, J.Y. Chen and I.C. Lai, Cytochrome P-450 2D6*10 C188T polymorphism is associated with antipsychotic-induced persistent tardive dyskinesia in Chinese schizophrenic patients, Neuropsychobiology 49 (2004), 167-173.
25. D.K.Y. Chan, J.Woo, S.C. Ho et al., Genetic and environmental risk factors for Parkinson's disease in a Chinese population, J Neurol Neurosurg Psychiatry 65 (1998), 781-784.
26. U.M. Zanger, S. Raimundo and M. Eichelbaum, Cytochrome P4502D6: overview and update on pharmacology, genetics, biochemistry, Naunyn Schmiedebergs Arch Pharmacol 369 (2004), 23-37.
27. T. Fukuda, Y. Nishida, S. Imaoka, T. Hiroi, M. Naohara, Y. Funae and J. Azuma, The decreased in vivo clearance of CYP2D6 substrates by CYP2D6*10 might be caused not only by the low-expression but also by low affinity of CYP2D6, Arch Biochem Biophys 380 (2000), 303-308.
28. I. Johansson, M. Oscarson, Q.Y. Yue, L. Bertilsson, F. Sjoqvist and M. Ingelman-Sundberg, Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation, Mol Pharmacol 46 (1994), 452-459.
29. T.L. Poulos, B.C. Finzel and A.J. Howard, High resolution crystal structure of cytochrome P450 cam, J Mol Biol 195 (1987), 687-700.
30. M. Bialecka, G. Klodowska-Duda, K. Honczarenko, B. Gawronska-Szklarz, G. Opala, K. Safranow and M. Drozdzik, Polymorphisms of catechol-o- methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome p450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease, Parkinsonism Relat Disord 13 (2007), 224-229.